Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Travere Therapeutics Inc (NQ: TVTX ) 10.11 +0.32 (+3.29%) Streaming Delayed Price Updated: 10:19 AM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Travere Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > 10 Health Care Stocks Whale Activity In Today's Session July 10, 2024 Via Benzinga Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday July 09, 2024 Via Benzinga Expert Outlook: Travere Therapeutics Through The Eyes Of 6 Analysts May 07, 2024 Via Benzinga TVTX Stock Earnings: Travere Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 06, 2024 TVTX stock results show that Travere Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Critical Insights From Travere Therapeutics Analyst Ratings: What You Need To Know April 17, 2024 Via Benzinga Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights March 13, 2024 Via Benzinga Deep Dive Into Travere Therapeutics Stock: Analyst Perspectives (7 Ratings) February 16, 2024 Via Benzinga Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Earnings Preview For Travere Therapeutics February 14, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For Travere Therapeutics January 18, 2024 Via Benzinga Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug December 21, 2023 The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy... Via Benzinga Exposures Product Safety Where Travere Therapeutics Stands With Analysts December 15, 2023 Via Benzinga THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday December 06, 2023 U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities What's Going On With Travere Therapeutics Stock? December 05, 2023 Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday. Via Benzinga Where Travere Therapeutics Stands With Analysts November 20, 2023 Via Benzinga Preview: Travere Therapeutics's Earnings November 06, 2023 Via Benzinga Expert Ratings for Travere Therapeutics September 22, 2023 Via Benzinga Crude Oil Moves Lower; AutoZone Profit Tops Views December 05, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 05, 2023 Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 05, 2023 Via Benzinga NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday December 05, 2023 U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's After-Market Session December 04, 2023 Via Benzinga Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday September 22, 2023 Loop Capital increased the price target for Splunk Inc. (NASDAQ: SPLK) from $135 to $157. Loop Capital analyst Yun Kim downgraded the stock from Buy to Hold. Splunk shares fell 0.1% to $144.25 in... Via Benzinga Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges September 21, 2023 William Blair downgraded Travere Therapeutics Inc (NASDAQ: TVTX) Via Benzinga Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 September 22, 2023 Via Benzinga Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit September 21, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session September 21, 2023 Via Benzinga Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session September 21, 2023 Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Via Benzinga Why Shares of Travere Therapeutics Are Slumping Thursday September 21, 2023 A mixed trial could hurt a kidney drug's chances of full approval. Via The Motley Fool < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.